Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

University of Massachusetts, Worcester

Status: Completed

Conditions: Lung Cancer

Treatments: Behavioral: Tele-Navi LCS

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05021133

H00022916

P50CA244693 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

Enrollment: 22 patients

Sex: All

Ages: 50 to 77 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Is eligible for LDCT for LCS follow-up
• Has technology to complete study activities (e.g., video call visit)
• English speaker
• Has undergone LCS at UMMH
• Is overdue for LDCT follow-up

Exclusion criteria

• Has previous diagnosis of lung cancer
• Has active cancer diagnosis
• Is a nursing home or group care resident
• Is pregnant

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Tele-Navi LCS

Other group

Description:

Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS

Treatment:

Behavioral: Tele-Navi LCS